The experimental antiviral drug Molnupiravir is expected to become available in Slovenia from tomorrow to treat vulnerable patients with COVID-19.
The experimental antiviral drug Molnupiravir is expected to become available in Slovenia from tomorrow for the treatment of COVID-19, especially for vulnerable patients who have higher risk factors or underlying health issues.
The drug was originally developed to treat a different virus but showed strong results in fighting other viruses, such as influenza and Ebola.
It's name was inspired by the name of Thor's hammer, Mjolnir.
Voluntary vaccination of children aged between 5 and 11 is also expected to begin next week.
news source
https://www.rtvslo.si/radio-si/news/experimental-antiviral-drug-to-become-available-in-fight-against-covid/604769
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.
US pharmacies reportedly set purchase limit on emergency contraception pills
INCEPTA Pharmaceuticals Ltd is proud to become one of the 27 companies to sign licensing agreement with the Medicines Patent Pool (MPP)
Japan OKs Pfizer Covid-19 oral pills amid surging infections
Disposable Face Masks vs Reusable Face Masks
Surgical Face Masks V/S Respirators
How do Respirators Actually Work?
Type IIR Masks - How they are Manufactured ?
We can offer You Made In Uk Masks and competitive prices
Glenmark and SaNOtize introduce nasal spray to treat Covid-19 in India
India gives Việt Nam COVID-19 vaccines and raw materials to make COVID drugs
COVID-19 pills could spark scramble among nations
Square launches Molnupiravir in local mkt